-
-
-
-
-
-
-
Rexahn Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Rexahn Pharma (RNN) Reports Q1 Loss of $0.02
-
-
-
-
-
-
-
Rexahn Pharma (RNN) Appoints New Board Chairman
-
-
-
-
-
-
-
Pre-Open Stock Movers 9/25: (LPDX) (CYBR) (RNN) Higher; (FUL) (OMN) (PCRX) Lower (more...)
-
-
-
-
-
-
-
Rexahn Pharma (RNN) Updates on FY13 Results; Sees Completion of Supinoxin Phase I in Q414
-
-
-
-
-
-
-
Morning Movers 12/02: WBD, KKD, OREX, MCOX, RNN, INAP, PSS, MOV Higher; ARO, INSM, KR, JAS Lower
1,197,519 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

